BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 20541652)

  • 1. FDG PET/CT in oncology: "raising the bar".
    Patel CN; Goldstone AR; Chowdhury FU; Scarsbrook AF
    Clin Radiol; 2010 Jul; 65(7):522-35. PubMed ID: 20541652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Established, emerging and future roles of PET/CT in the management of colorectal cancer.
    Herbertson RA; Scarsbrook AF; Lee ST; Tebbutt N; Scott AM
    Clin Radiol; 2009 Mar; 64(3):225-37. PubMed ID: 19185652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical PET/CT imaging: promises and misconceptions.
    Czernin J; Auerbach MA
    Nuklearmedizin; 2005; 44 Suppl 1():S18-23. PubMed ID: 16395974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Established, emerging and future applications of FDG-PET/CT in the uterine cancer.
    Kitajima K; Murakami K; Kaji Y; Sakamoto S; Sugimura K
    Clin Radiol; 2011 Apr; 66(4):297-307. PubMed ID: 21356392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardization and quantification in FDG-PET/CT imaging for staging and restaging of malignant disease.
    Gámez-Cenzano C; Pino-Sorroche F
    PET Clin; 2014 Apr; 9(2):117-27. PubMed ID: 25030277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. False-positive uptake on 2-[¹⁸F]-fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) in oncological imaging.
    Culverwell AD; Scarsbrook AF; Chowdhury FU
    Clin Radiol; 2011 Apr; 66(4):366-82. PubMed ID: 21356398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [FDG-PET/CT in oncology. German Guideline].
    Krause BJ; Beyer T; Bockisch A; Delbeke D; Kotzerke J; Minkov V; Reiser M; Willich N
    Nuklearmedizin; 2007; 46(6):291-301. PubMed ID: 18084685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical applications of positron emission tomography-computed tomography in oncology.
    Kumar R; Halanaik D; Malhotra A
    Indian J Cancer; 2010; 47(2):100-19. PubMed ID: 20448371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET/CT-guided radiation therapy planning: from present to the future.
    Gupta T; Beriwal S
    Indian J Cancer; 2010; 47(2):126-33. PubMed ID: 20448373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers.
    Menda Y; Graham MM
    Semin Nucl Med; 2005 Oct; 35(4):214-9. PubMed ID: 16150243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [18F]FDG PET/CT imaging of colorectal cancer: a pictorial review.
    Chowdhury FU; Shah N; Scarsbrook AF; Bradley KM
    Postgrad Med J; 2010 Mar; 86(1013):174-82. PubMed ID: 20237012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The contribution of PET to radiation treatment planning].
    Belkacémi Y; Lartigau E; Kerrou K; Carpentier P; Taïeb S; Giraud P
    Bull Cancer; 2007 Jan; 94(1):99-108. PubMed ID: 17237010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two decades at the cross-roads of biology, physics and epidemiology: lessons learned in [18F-]FDG positron emission tomography in oncology.
    Rizvi SN; Comans EF; Boellaard R; van Tinteren H; Hoekstra OS
    Eur J Cancer; 2010 Aug; 46(12):2150-8. PubMed ID: 20561780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG PET/CT in infection and inflammation--current and emerging clinical applications.
    Vaidyanathan S; Patel CN; Scarsbrook AF; Chowdhury FU
    Clin Radiol; 2015 Jul; 70(7):787-800. PubMed ID: 25917543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pivotal role of FDG-PET/CT in modern medicine.
    Hess S; Blomberg BA; Zhu HJ; Høilund-Carlsen PF; Alavi A
    Acad Radiol; 2014 Feb; 21(2):232-49. PubMed ID: 24439337
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Chambers G; Frood R; Patel C; Scarsbrook A
    Br J Radiol; 2019 Feb; 92(1094):20180584. PubMed ID: 30383441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma.
    Chowdhury FU; Bradley KM; Gleeson FV
    Clin Radiol; 2008 Dec; 63(12):1297-309. PubMed ID: 18996259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET.
    Antoch G; Saoudi N; Kuehl H; Dahmen G; Mueller SP; Beyer T; Bockisch A; Debatin JF; Freudenberg LS
    J Clin Oncol; 2004 Nov; 22(21):4357-68. PubMed ID: 15514377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.